Hindustan Time

Thursday, 19 November 2020

Covid-19 vaccine update: Covaxin phase 3 trials to begin in Haryana today, minister...

Adar Poonawalla, the chief executive of Serum Institute of India, said his company may sell Covishield, the Covid-19 vaccine being developed by Oxford University, for around Rs 500-600 per shot.

from Hindustan Times - india https://ift.tt/390LLWS

No comments:

Post a Comment